Clinical Trials Browser

NIH × Pioglitazone × Head & Neck × Clear all

NCT00099021 2022-02-11

Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Phase 2 Completed

21 enrolled 6 charts

Head and Neck Neoplasms, Leukoplakia, Oral

NCT00951379 2016-04-06

Pioglitazone for Oral Premalignant Lesions

Phase 2 Terminated

52 enrolled 23 charts

Leukoplakia, Oral